`
`‘
`
`
`
`mahmvmmdiwmm
`
`l
`AstraZeneca Exhibit 2044 p.
`11'1110Pharma Licensing LLC‘ v. AstraZeneca AB [PR2017-00904
`
`
`
`H'l
`
`INNOVATIVE RESEARCH OF AMERICA
`
`— M
`
`ost scientists agree that the three essential parameters in the success of a biomedical
`experiment are:
`
`A. The scientific problem formulated in a defined question.
`
`B. The laboratory animal, healthy and untraumatized.
`
`C. The process of active product delivery; the most problematic variable of all three!
`
`For a third of a century, Innovative Research of America has assumed the leadership role
`
`in improved time release technology. The main mission is to standardize the technology of
`
`drug delivery. Our proven Time Release Hormone and Drug Pellets help investigators take
`
`charge of product delivery and expand their abilities to do meaningful and reproducible
`
`research.
`
`ADVANTAGES OF THE PELLET DELIVERY SYSTEM
`* aready-toradminister pelletforaSimple subcutaneousimplantation
`l
`
`'
`
`I
`
`:
`
`I
`
`Ushering In The Age Oflnnovathe Research
`
`AstraZeneca Exhibit 2044 p. 2
`
`
`
`HORMONE AND DRUG PELLETS FOR BIOMEDICAL RESEARCH
`
`—
`
`Since it is not easy to administer drugs and hormones orally to research animals,
`
`several delivery methods have been devised as alternatives. However, most scientists
`
`continue to labor with unreliable injectables to conduct their research.
`
`Because of this inadequacy. biomedical research is as confusing as it is challenging
`
`and as frustrating as it is creative. The options of scientists to address scientific questions
`
`are not only dependent, but are also limited by the process of active product delivery.
`
`Traditionally, product delivery into the experimental animal has been the procedure most
`
`subject to variables and the most difficult to standardize effectively. The very process
`
`of having to accurately administer drugs to experimental animals can become a logistic
`
`nightmare for scientists.
`
`CHANGING THE TIME COURSE OF DRUG DELIVERY
`
`We Tell Ti inc—Release Pellets What Time It Is
`
`AstraZeneca Exhibit 2044 p. 3
`
`
`
`Find a Product in this Catalog .......................................................... 5
`
`Ordering information I General Policy & Terms ............... 6, 7, 44, 84
`
`Sales of Anabolic Steroids ............................................................... 8
`
`Category Index............................................................................ 10-15
`
`Alkaloids
`Amino Acids
`Androgens
`Antibiotics
`Anti~lnf|ammatory Agents
`Anti—Neoplastics
`Catecholamines
`Corticoids and Diuretics
`
`Estrogens
`Fatty Acids
`Nucleotide Related Products
`Progestins
`Prostaglandins
`Thyroids
`Vitamins
`
`IRA TABLE OF CONTENTS
`
`
`
`Placebo Peiietei'ntoIm-ation. F" ~
`
`Alphabetical Product Listing ..................................................... 21 -42
`
`Stock Pellet Price Schedules ..................................................... 45-71
`
`Pellets for lmmuno—Deficient Mice
`
`17B-Estradiol [Tamoxifen 8: Sample References ..................... 73-77
`
`Androgens I Anti-Androgens 8: Sample References ............... 78—80
`
`Trochar 8: Recommended Implantation Procedure ............... 81,123
`
`Doxycycline 8: Tetracycline Pellets in Mice .............................. 85-86
`
`Hormone + Hormone Pellets ..................................................... 89-92
`
`Custom Pellets .......................................................................... 93-108
`
`Selected References ............................................................... 109-122
`
`Order Forms .............................................................. Back of Catalo -
`
`Patents ................................................................... inside Back Cover
`
`*Forfirrther assistance, view our website at:
`wwwin novrsrch.com
`
`We Add Time To Your Day
`
`AstraZeneca Exhibit 2044 p. 4
`
`
`
`PRODUCT DESIGN AND FEATURES
`
`
`
`The Pellet Implantation Methodology provides solutions to:
`
`.. consistency in timing repeated product administrations.
`
`controlling the amount of product administered.
`
`stability of the product preparation.
`
`.. safety of the experimenter.
`
`.. neurophysiological trauma to the animal from excessive handling.
`
`.. freeing valuable research time.
`
`.. eliminating unnecessary and unstimulating laboratory practices.
`
`Scientists from several research disciplines have documented in scientific literature that
`
`our Pellet Delivery System is effective, consistent, reproducible, economical, reliable, and
`
`safe for the animal. See Selected References on pages 109-122.
`
`Only Time. Release Pellets Really Know What Time [I ls
`
`AstraZeneca Exhibit 2044 p. 5
`
`
`
`PRODUCT SPECIFICATIONS
`
`AVAILABLE SHAPES AND SIZES
`
`Stock pellets are round and range in diameter from US” (3 mm) to 1/2” ( 1.25 cm) depending on the
`dose and the release rate. Our Custom Pellets Department will also design various pellet shapes and
`smaller sizes (Page 94) to meet your research needs. Please refer to the Custom Pellets section on pages
`93-108.
`
`AVAILABLE DOSAGES
`
`Most of the stock products in this catalog are available in 20 different dosages ranging from 1 microgram
`(0.001 mg) per pellet up to 200 milligrams (200 mg) per pellet within the specified release rate. Doses of
`pellets listed in this catalog reflect the total amount of not active product released over the indicated
`period of time.
`
`AVAILABLE RELEASE RATES
`
`Stock products are designed to release continuously for 21 days, 60 days, or 90 days. Please refer to our
`Custom Pellets section on pages 93- 108 for other release rates tailored for the duration of the experiment.
`
`AVAILABLE PRODUCTS
`
`In our continuing quest to make available new stock items that are particularly in demand, we have added
`several products to the original categories. In addition to the listed pelletized products, Innovative
`Research of America has an efficient Custom Pellets Department to prepare products that are not available
`as stock items.
`
`SELECTED REFERENCES
`
`A sample of publications that employed our delivery system in a broad spectrum of products can be found
`on pages 109-122.
`
`Consistent Dose-Dependent Release
`
`AstraZeneca Exhibit 2044 p. 6
`
`
`
`FINDING A PRODUCT IN THIS CATALOG
`
`—
`
`The PRODUCTS in this catalog are arranged in ALPHABETICAL ORDER and are identified by
`a CATALOG NUMBER and a PRICE SCHEDULE with 3 PAGE NUMBER.
`
`The catalog number and price schedule reflect a release rate of 21 days, 60 days, or 90 days.
`
`To illustrate with lill-Estradiol as an example:
`
`EXAMPLE
`
`Product
`
`21-Day Release
`Catalog
`Price Scheduler
`Number
`Page Number
`
`60-Day Release
`Catalog
`Price Schedule!
`Number
`Page Number
`
`90-Day Release
`Catamg
`Price Schedule!
`Number
`Page Number
`
`
`
`173 Estradiol
`
`E- 121
`
`B-2lf48
`
`SE-121
`
`B—60.’49
`
`NE- 121
`
`13-9050
`
`
`
`The above example indicates that l7B-Estradiol is available in three release forms each having a
`
`different catalog number and price code, Le.
`
`E - 121 is a 21-day release form with a price code of 8-21, found on page 48.
`
`SE - 121 is a 60—day release form with a price code of 3-60, found on page 49.
`
`NE - 121 is a 90-day release form with a price code of B-90, found on page 50.
`
`The PAGE NUMBER next to the PRICE SCHEDULE indicates the page where the actual price
`
`for the product appears.
`
`When ordering please use the PRODUCT NAME, CATALOG NUMBER, RELEASE
`
`RATE and DOSE. Most products are available in 20 different dosages. Products are sold in
`
`Lots of 25, 50, 100, and 200 pellets. Please indicate the quantity of pellets being ordered.
`
`Beginning on Page 10 we. have grouped some of our catalog items in related categories
`
`alphabetically. We hope the listing will help in noting items of potential interest.
`
`"lime-Release Pellets... Always On Time
`
`AstraZeneca Exhibit 2044 p. 7
`
`
`
`
`
`
`- Internet I E-Mail
`
`Innovative Research of America, Inc.
`
`httpdlwwwinnovrsrchxom (website)
`
`2 North Tamjamj Trail
`
`pellets@innovrsrch.com (e-mail)
`
`Suite 404
`
`Sarasota, Florida 34236 USA
`
`‘- Phone
`
`(941) 365-1406
`
`(941) 365-1506
`(800) 421-8171 (USA/Canada)
`
`' Fax
`
`(941) 365-1703
`
`E830; 24618-41122: (USNCanada)
`
`(800) 648-6030 (USA/Canada)
`
`IRA’s website features our company profile,
`the latest product technology and on-line ordering.
`
`- AMERICAN EXPRESS
`
`__ VISA AND MASTERCARD ACCEPTED.
`__
`Purchase Order Forms are in the back of the
`
`“3‘8'09'
`
`J Custom Pellets Information Form on page 95.
`
`Bank Wire Payment Information
`Reymenr via bank wire should be directed as follows:
`
`THE Dll‘FEKENCE lS
`CONSISTENCY AND HNlFOKMlTY.
`
`““33“"
`1800 Second St., Suite I00
`Sarasota. Florida 34236
`
`Routing # (ABA) 263191387
`Eleclronic Transfers # 263191387
`
`In favor of:
`Innovative Research of America
`
`Swift Code: BRBTU833
`
`2 North Tamiami Trail
`Suite 404
`
`Sarasota, FL 34236
`
`Checking Account: #0000147816154
`
`Ushering In The Age Of lrmovative Research
`
`AstraZeneca Exhibit 2044 p. 8
`
`
`
`GENERAL POLICY AND TERMS
`
`
`
`
`
`
`.
`4'1.
`.
`..
`..
`.
`
` m ”A“
`:. éfiipmdyg
`I 2*?
`
`
`
`AstraZeneca Exhibit 2044 p. 9
`
`
`
`SALE OF CONTROLLED ANABOLIC STEROIDS
`
`within the United States
`
`— (
`
`Telephone orders will not be accepted - orders & copy of DEA license may be mailed or faxed)
`
`Before we can prepare any orders of Anabolic Steroid Pellets, the Drug
`
`Enforcement Administration (DEA) requires us to obtain:
`
`1. A valid photocopy of the investigator’s DEA Registration
`
`containing Schedule 3N.
`
`2. A written Purchase Order showing the investigator’s DEA
`
`Registration Number and proper shipping address.
`
`CONTACT INNOVATIVE RESEARCH OF AMERICA
`
`BY PHONE, MAIL, FAX OR E-MAIL
`
`FOR MORE ORDERING INFORMATION - SEE PAGE 6
`
`SALE OF CONTROLLED ANABOLIC STEROIDS
`
`outside the United States (International)
`—
`
`WE NO LONGER SHIP ANABOLIC STEROIDS
`
`outside the United States (International)
`
`DEA Controlled Anabolic Steroids
`
`Androstenediol
`
`19~Nortestosterone l7-Decanoate
`
`Androstenedione
`
`lQ—Nortestosterone 17-Dipropionate
`
`SOL-Dihydrotestosterone
`
`Fluoxymesterone
`
`Mcsterolone
`
`Mesterone
`
`Methandriol
`
`Methandriol Dipropionate
`
`Stanozolol
`
`Testosterone
`
`Testosterone Acetate
`
`Testosterone Benzoate
`
`Testosterone Cypionate
`
`Testosterone Enanthate
`
`l9-Nortestosterone
`
`Testosterone 1 7r3— Hemisuccinate
`
`.l'-'
`
`Testosterone Propionate
`
`Time Release Pellets Always On Time.
`
`AstraZeneca Exhibit 2044 p. 10
`
`
`
`U1
`
`'4
`
`and specific references.
`
`See pages 73-80 regarding
`Hormone/Anti-Hormone products
`for Immune-Deficient Mice
`
`Your Research Time Is Under Your Control
`
`AstraZeneca Exhibit 2044 p.
`
`l l
`
`
`
`CATEGORY INDEX
`
`On the following 6 pages, we have grouped some of our Catalog items in related categories.
`Hopefully this listing will help in noting items of potential interest.
`
`ALKALOIDS
`
`ME .
`
`
`
`Reliable Deli\-'e1'_\,-' “ystem For Global Discm'el'ies
`
`10
`
`ll
`
`AstraZeneca Exhibit 2044 p. 12
`
`
`
`We Add A Little. Ti [11C To Your Day
`
`
`
`AstraZeneca Exhibit 2044 _
`
`
`
`
`
`
`
`
`
`12
`
`It's Time. For Clear, Comislcm Results
`
`AstraZeneca Exhibit 2044 _
`
`
`
`CATEGORY INDEX (continued)
`
`
`
`When Reliability C011 n [5
`
`AstraZeneca Exhibit 2044 p. 15
`
`
`
`CATEGORY INDEX (continued)
`
`
`
`AstraZeneca Exhibit 2044 p. 16
`
`
`
`CATEGORY INDEX (continued)
`
`‘."
`
`Consistent Results With Consistent Relea.
`
`AstraZeneca Exhibit 2044 p. I?
`
`
`
`ADVANTAGES OF OUR MDD PELLET SYSTEM ; __
`
`‘
`
`. Saves time
`
`o Ready-to-implant
`
`.
`Insures controlled product release over time
`o Avoids “peak and valley” effects
`
`i
`I
`
`o Guarantees consistent product preparation
`
`. Extends product life against spontaneous breakdown
`
`o Extends product life against host-related breakdown
`
`. Minimizes experimental variables
`
`.
`
`Insures safety of the researcher
`
`o Reduces neurophysiological trauma to the animal!
`
`norwcessive handling
`
`9 Generates more meaningful and reproducible results
`
`9 Superior to conventional delivery methods
`
`. Enhances experimental efficiency
`
`0 Frees valuable time for creative research
`
`9 Saves money
`
`Time—Release. Pellets... Always On Time
`
`AstraZeneca Exhibit 2044 p. 18
`
`
`
`I;
`
`
` PLACEBO / CONTROL
`PELLETS
`
`
`
`
`
`i
`
`1
`
`II
`
`Matching Placebo pellets contain all the components of the hormone or drug pellet except the active
`product itself. The carrier-binder excepients of the matrix include Cholesterol, Lactose, Celluloses,
`Phosphates and Stearates.
`
`Stock Placebo pellets are available in 20 different doses corresponding to those of active product
`pellets. Each dose is offered in either 2] Day, 60 Day, or 90 Day Release form.
`
`Although the matrixes in Placebo pellets have a different composition for different active products,
`they are all assigned the same catalog number and are offered at the same price schedule.
`
`When inquiring or placing an order, please specify the active product you wish to correspond the
`Placebo pellets for. Please see the following examples:
`
`Catalog No.
`
`Description
`
`Dose in mgfpellet
`
`Release in Days
`
`5'
`
`C-lll
`
`SC-l l 1
`
`NC-lll
`
`Placebo for “Active Product" _ wig/pellet
`
`Placebo for “Active Product“
`
`Placebo for “Active Product”k
`
`mg/pel let
`
`rug/pellet
`
`21 Day
`
`60 Day
`
`90 Day
`
`I;
`
`‘;
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`*In place of “Active Product” specify the hormone or drug you are utilizing in your study.
`
`The following three pages are universal dose fprice schedules in all three release rates (21 Day, 60
`Day, and 90 Day) and are applicable as a matching Placebo for all products in the catalog except
`special physical size and preparations (page 94) which can be found under the Custom Pellet section
`on pages 93-108.
`
`
`
`
` *Please inquire directly with as iffllrt‘her assistance is required regarding a product ofinterest.
`
`AstraZeneca Exhibit 2044 p. "l 9
`
`
`
`
`
`AstraZeneca Exhibit 2044 p. 20
`
`
`
`
`
`olood
`
`0.010
`
`'
`
`0.025
`
`0.05
`
`0.1
`
`0.25
`
`0.5
`
`1.5
`
`2.5
`
`5.0
`
`$697
`
`$697
`
`$697
`
`$697
`
`$697
`
`$697
`
`$697
`
`$697
`
`$697
`
`$697
`
`$1362,
`
`$1362
`
`$1362
`
`$1362
`
`$1362
`
`$1362
`
`$1362
`
`$1362
`
`$1362
`
`$1362
`
`$2649
`
`$2649
`
`$2649
`
`$2649
`
`$2649
`
`$2649
`
`$2649
`
`$2649
`
`$2649
`
`$2649
`
`$4816
`
`$4816
`
`$4816
`
`$4816
`
`$4816
`
`$4816
`
`$4816
`
`$4816
`
`$4816
`
`$4816
`
`$4858
`
`7.5
`
`10.0
`
`15.0
`
`25.0
`
`35.0
`
`50.0
`
`75.0
`
`100.0
`
`150.0
`
`200.0
`
`$702
`
`$702
`
`$702
`
`$707
`
`$707
`
`$707
`
`$707
`
`$718
`
`$718
`
`$723
`
`$1379
`
`$1379
`
`$1379
`
`$1386
`
`$1386
`
`$1386
`
`$1386
`
`$1406
`
`$1406
`
`$1415
`
`$2674
`
`$2674
`
`$2674
`
`$2674
`
`$2674
`
`$2674
`
`$2674
`
`$2734
`
`$2734
`
`$2744
`
`$4858
`
`$4858
`
`$4875
`
`$4875
`
`$4875
`
`$4875
`
`$4945
`
`$4945
`
`$4964
`
`A combination of multiple dosages in one lot, for any specified product, is also
`available. PLEASE INQUIRE.
`
`Sixty and Ninety day price schedules are on the following two pages.
`
`
`
`AstraZeneea Exhibit 2044 p. 21
`
`
`
`
`
`PLACEBO PELLETS -:
`
`
`sir-4 _.
`
`
`
`_»
`.
`
`u
`
`5-,...
`d
`
`
`
`PRICE SCHEDULE
`
`Cat. No. SC—lll
`
`
`
`200.0
`
`$51 97
`
`A combination of multiple dosages in one lot, for any specified product, is also
`available. PLEASE WQLURE.
`
`
`
`AstraZeneea Exhibit 2044 p. 22
`
`
`
`—v~]
`
`-
`
`-_-_-
`-._.._....—___ .- ._.._..._..-_.H— _‘_..--.._.-__ _._‘___ ._...'-+._.
`.—1-:-r-v "7".— ‘——..'—_ —F —.——--—r'r'—"-“ ——r-"‘.'7:*-"' W-n‘rrer-w .: w __... —"7".‘;-.-.IT'_->|rru-Hz""'“-""—-I"I _
`.
`.. ----a-.»—-—_.
`
` PLACEBQ PELLETL
`
`.H— _..J
`
`--. —-
`
`PRICE SCHEDULE
`
`Cat. No. NC-l 11
`.._-
`.
`-w'}-4rh:¢'__".‘,.-':
`'- "1512,35; ”trig-g,
`
`_.
`
`_.
`“‘41-" Raid” .'
`
`'
`
`¢
`
`'
`
`
`
`
`A combination of multiple dosages in one lot, for any specified product, is also
`available. PLEASE UVQUIRE.
`
`AstraZeneca Exhibit 2044 p. 23
`
`
`
`BIOMEDICAL RESEARCH IN
`
`MultI-Steplnjectlons reaCentmueus Painin DRUG DELIVERY
`
`
`
`One-Step COntiil‘iIfiIIS _:Releas_e Pellets Are the Best Alternative
`
`Time Release Pellets
`
`for Biomedical Research from IRA
`nose
`
`O)))))))))))))))))))
`
`
` TIME RELEASE PELLETS FOR
`LABORATORY ANIMALS
`
`
`
`O))))))))))))))
`
`Q))))))))))))
`
`
`TIME
`
`
`
`
`and Innovative Scientists
`
`deserve.
`
`RELEASE
`
`
`Our Team at IRA is working
`
`to meet the responsibility that
`
`Innovative Science demands
`
`
`
`
`
`AstraZeneca Exhibit 2044 p. 24
`
`
`
`To illustrate with Acetazolamide as an example, please View the following table:
`
`Product Name
`
`2! Day Release
`
`60 Day Release
`
`90 Day Release
`
`Catalog
`Number
`
`Price Schedule.Jr
`Page Number
`
`Acetazolamide
`
`D~lll
`
`C21 i5]
`
`Catalog
`Number
`
`SD~lll
`
`Price Schedule!
`Page Number
`
`Catalog
`Number
`
`Price Schedule:r
`Page Number
`
`C60 ! S2
`
`ND-lil
`
`C90 f 53
`
`The PRODUCT NAMES in this catalog are arranged in ALPHABETICAL
`ORDER and are identified by their individual CATALOG NUMBERS including 3
`PRICE SCHEDULE and corresponding PAGE NUMBER. The catalog number and
`price schedule reflect a release rate of 21 Days, 60 Days. or 90 Days.
`
`Maximum Flexibility
`
`The above example indicates the stock productAcetazolamide is available in three release
`forms each having a different catalog number and price code, i.e.
`
`D-Ill is a 2| Day Release form with a price code of C-Zl, found on page 51.
`
`30-1 11 is a 6!} Day Release form with a priCe code of C360, found on page 52.
`
`ND-lll is a 90 Day ReleaSe form with a price code of (3-90. found on page 53.
`
`The PAGE NUMBER next to the PRICE SCHEDULE indicates the page where the actual
`price for the product appears.
`
`When placing an order. please include the PRODUCT NAN-l IE, CATALOG NL'M BER, DOSE IN
`MGIPELLET and RELEASE RATE. Most of our products are available in 20 different doses.
`Products are normally sold in lots of 25. 50, 100, and 200 pellets. Please indicate the quantity
`of pellets to be ordered.
`
`Beginning on page i0, we have grouped some of our catalog items by related categories
`alphabetically. We hope the listing will help in noting items of potential interest.
`
`*Please inquire directly: with us iffurther assistance is required regarding a product ofinterest.
`
`AstraZeneca Exhibit 2044 p. 25
`
`
`
`
`
`
`
`...._._-_—'._-.-—-_—.—....-.:E-u---
`
`
`
`AstraZeneca Exhibit 2044 p. 26
`
`
`
`ALPHABETICAL PRODUCT LISTING
`
`— D
`
`ose/Price Schedules For Matching Placebo Pellets Appear On Pages 17-19.
`
`21-Day Release
`(Tatulng Price. Schedule!
`Number Page Number
`
`60-Day Release
`Catalog l‘l'iee Schedule!
`Numher Page Number
`
`90-Day Release
`Catalog Price Schedule}
`Numher Page Number
`
`Acebutolol
`
`8-21148
`
`SC-101
`
`B-GOMQ
`
`NC-101
`
`B-QOI'SU
`
`ACBlEmIdOfiuoreneflAAF) ” '
`
`Acetarsone
`
`3": Acetamlamee
`Acempromazine
`
`8-212'48
`
`B—60l49
`
`.
`
`.
`
`.
`
`_
`
`__
`
`.
`
`..
`
`0192
`
`950919
`
`I N—Aeetyi-L-Cysteine
`
`0-212
`
`3-21:49'
`
`9-9999 I
`
`N-Acetylimidazoie
`I
`lprocamamlde _
`sis-Aconitic Acid
`
`_
`
`I
`
`._
`
`-_
`
`_
`
`Q-2?3
`9-2949
`SQ-2?3
`B-60!4Q
`. 0-106 A21f45 30-106
`K411
`B-21f48
`SK-111
`B-BUMQ
`
`8-90! 50
`
`.
`.
`9-9959
`
`99950
`
`999150
`
`
`
`-AE§niti¢-Acid
`
`__'-:K-1'12
`K413
`
`'- 0-:2'953; SK11ZCGOI52
`5-2957
`SK-113
`E~60!58
`
`I
`
`.
`5-9059
`
`: {2-110 .. 191-2159192419 H60!61H90!62
`
`SN-m c-eor52
`(3-2951
`N-111
`" e196 .. 821MB = 39119 3:30:49
`9-11?
`3-2949
`SG-‘l1?
`9—9099
`
`(3-9953
`H 99:59
`9-9959
`
`2.199 f 921.99 32150.}. 99951.; H9962
`9-135
`9-2943
`90135
`B-SOI4Q
`999159
`0-131
`' C-z'iir'éfif --.".89%13'1 99-99525
`999/53
`
`0-111
`0-121 I
`3-166
`
`3-2949
`9-2951]
`9.2949
`
`90—111
`3-5999
`sci-1.21 b.6952
`99.199
`3-9-9149
`
`B-QOISO
`(399153
`9.9050
`
`1.111
`
`9-2949
`
`SI-m
`
`13-9999
`
`13-9959
`
`-A’-193--
`c-431
`
`Aéé-1I3J4i5:
`0-2954
`
`ISA-33193-
`90-431
`
`IAIQQOQBI'T 5.599034}:-
`0—99355
`-
`0-9955
`
`21
`
`AstraZeneca Exhibit 2044 p. 27
`
`
`
`ALPHABETICAL PRODUCT LISTING
`
`DosefPriee Schedules For Matching Placebo Pellets Appear On Pages 17-19.
`
`21-Day Release
`Camille. Price Selwtlnle;II
`Numher Page Number
`
`60-Day Release
`Calalug l’riee SchedulesI
`Number Page. Number
`
`90-Day Release
`(fuming l’riee .‘Selletlule;II
`Number Page Number
`
`Althiazlde
`
`A-104
`
`13-21140
`
`SA— 104
`
`B-GUMB
`
`NA-104
`
`13-90150
`
`Amaadlne
`1005500
`
`'-..-;
`
`._
`
`Amllonde _.
`_ Amineeeetehitrile H I
`
`'
`
`" -M01ifieaceitb'ph'éqon-e_j-'
`
`.
`
`m-Aminoacetophenone
`._:F_tA_minb§Cgtdpng-non¢...
`IAminoglutetfiimide
`
`--
`
`'-
`
`.r.353-63.???indpénieiiizliahipAcid
`
`Aminophylline
`
`'
`
`I
`
`.
`
`-
`
`'
`
`-
`
`13-157 .'.3'-_2'11148 50-107
`0-110
`A-21145
`86-118
`
`-:pl-131.
`0-105
`
`13-21143 ._ 30-131
`13-21140
`30-105
`
`3-00.09
`A-60i46
`
`B—601'49
`3-601'49
`
`010-151
`110-110
`
`13-0050.
`111-0014?
`
`ND-1'81
`100-105
`
`13-00150
`13-00150
`
`-0400.
`
`-
`
`A-211’45=
`
`3111-106
`
`A-60f46
`
`"NA-106
`
`01-00147
`
`0-107
`A408
`(3-281
`
`0-2048
`3-2040
`13-21154
`
`8131-10?
`SA-108
`80-201
`
`B-SOMQ
`13-50149
`0-50155
`
`NA-107
`NA-108
`rue-201
`
`300150
`51-90150
`13-90150
`
`513-111
`
`13-2-1143
`
`33-111
`
`300149 '
`
`- 1113-111
`
`13-90150
`
`0-125
`
`13-21151
`
`80-125
`
`13-60152
`
`NC-125
`
`000153
`
`
`
`_
`
`I
`
`.
`III-Aetazuolline
`
`Arachldlcctd
`
`__
`
`I
`
`".._ A101
`11-1-14
`
`j;-D;-..2___:115.41j
`' 13-2040
`
`:‘005101
`310114
`
`13-60155-
`”13-60149
`
`_
`
`--'-."._;;_{._1'-15-_-.
`'
`13-451
`
`13-21140:
`13-2-1151
`
`'-SI<_'-1'15_ 03-60149.”
`80-461
`13-60152
`
`00-101
`NK-114
`
`1010115
`NC-461
`
`13-90156
`13-90150
`
`..0-90'150
`13-00153
`
`.I
`
`F011-
`
`-_A-2.1145”_5F-f1_11_
`
`11-60146
`
`NF—111
`
`0-9014?
`
`ArachidonicAcid
`
`F-161
`
`11-21145
`
`SF-161
`
`A-SOMS
`
`NF-101
`
`11-00147
`
`22
`
`AstraZeneca Exhibit 2044 p. 28
`
`Ammopyr
`Amiodamné
`
`0-100
`0-112
`
`Amltrlptylme
`”061003-111th-
`
`H
`
`I
`
`II
`
`I
`
`'1
`
`_
`
`f. :70451 '
`13-112
`
`3-2043
`0-2040
`
`0-2-1151
`3-2040
`
`30-100
`Six-112
`
`30-451
`80-112
`
`13-00149
`13-00149
`
`0-00152
`13-00149
`
`NA-109
`010-112
`
`100451
`NB-112
`
`3-90150
`090150
`
`13-90153
`090150
`
`__
`
`I
`
`I
`
`IllAmgiJicillilsl'III-l-
`none
`” Afidrostle0ediol-
`
`'
`
`__ __
`
`"
`
`'
`
`I
`
`052.1154 00-113
`lief-"115;.
`000155;
`1113-113
`0-90156
`13-21148
`53-114
`0-114
`13-00140
`110-114
`13-90150
`-_
`;_:-_1_;3-'__-_10?-I " [10-21145 .. SC-107'-
`.A-00346._.
`Isle-10.7
`0-9014?-
`(meow-easesmgpggea,
`0-131
`13-21140
`30-131
`13-50149
`110-131
`13-00150
`A12132114080121 36014900421 3 800150
`0-141
`" 0-2051
`30-141
`13-00152
`1101-141
`0-9053
`
`
`
`
`
`ALPHABETICAL PRODUCT LISTING
`
`_ D
`
`osefPrice Schedules For Matching Placebo Pellets Appear On Pages 17-19
`
`21-Day Release
`
`60-Day Release
`
`90-Day Release
`
`C.‘Il'dlI'Jg PIiL‘I' Sulicdllld
`NIImhI'I l’.I<II: Number
`
`(Inning I‘riu! Scl‘ll‘tllllcf
`Numlwr I’Ige
`\umher
`
`I’IiCI: Schedule!
`{. Hilda};
`NIImLIeI Page Numhel
`
`-
`
`0-6052
`
`
`
`Arecoline
`
`L'Arginine
`D-AIsIearagine
`._sparaglne
`IIIIIbAspaIrzicAcid
`
`Aspartic Acid
`AspiIrin
`
`I
`
`_
`AIIopine
`II4IIAtropine Methyl Bromide
`3-Azaadenine
`
`Iggfizacytidine
`5III-Azacytosine
`4;
`B-Azahypoxanthine
`
`I_.I
`
`6-Azathymme
`
`I
`
`'
`
`'
`.'
`
`.
`
`I
`
`_
`
`.
`
`_
`
`_-
`
`II
`
`_
`
`-
`
`—
`'.
`
`-
`
`-
`
`_
`
`'_
`-I
`--
`—
`
`-
`-
`
`-
`
`-
`
`'
`
`.
`
`'
`
`
`
`IIcI-21I51IIII
`(:43)st
`'. C-21I51
`0-2151
`
`-II
`
`-
`
`II 06052
`I
`I-
`' "elm I.
`IIC-60i52
`Ic-60I52
`
`C9553
`" III-IIIII
`I
`
`IIc-IIOI53
`
`I
`II
`
`._ C9053
`06052
`C-21!51
`—
`060352
`-
`C-21l51I
`0-90(53
`342134332.“ .;__-.__f_é§IoI49-,.{.IT'BgorsoI
`cI-21III
`I
`II
`II
`cII-Ieostz II
`I-
`09053
`.C-2’Il_l5_1.I1I._..
`' C60z‘52
`;' C9053
`B-21I48
`B-BOMQ
`B~90IIIO
`
`:
`
`—
`
`II
`
`-
`
`AI21I4I5
`0-2151
`0-2-1151
`0-21351
`3421248 -
`
`Isa—21:48
`B_-2'1'I4_3;I
`c-21r51
`
`B:-2I.1'-f48'
`3-21II48
`
`-
`
`-
`
`I
`
`.
`
`-
`_—
`
`-
`
`-
`
`-
`
`-I A-fiO!45_
`6-6052
`' C-ons'zI
`I 0-6052
`'._B—60I49_
`
`.
`
`_
`
`'.
`
`-
`.2” I
`-
`
`I.
`
`-A_-.9__0I4'7
`(3-9053
`'C-Iébxss
`C-SIUIISIS
`359050-
`
`3:30:49
`-
`B~90!50
`-._.B.-$0I49__I I__ 3990350:
`0-60.62
`-I
`I
`CI-éorsaI
`
`' 3350:495ij 3:90:50
`8-60349
`-
`3-90I50
`
`AI2'1345-
`D-21I54I
`
`I
`
`--A_-6IOII'45-.t
`DI-soIss
`
`II
`
`—
`
`_'_I."AI.-I_SOI'4Z7I"
`D-QGISS
`
`0:21/54ff'IIj
`C-21f51II
`
`I
`
`-.
`
`D460Ij55Ef-I-I IjD-IQOISS'I
`{3-6052}
`II
`C—90I53
`
`23
`
`AstraZeneca Exhibit 2044 p. 29
`
`
`
`ALPHABETICAL PRODUCT LISTING
`
`I
`
`DoseJPrice Schedules For Matching Placebo Pellets Appear On Pages 17-19.
`
`21-Day Release
`Catalog Price Schedule!
`Number Page Number
`
`60-Day Release
`(29191011. Price S-iehedule1r
`Number Page Number
`
`90-Day Release
`Catalog Price Schedule!
`Numher Page Number
`
`Betamelhasone
`
`0-191
`
`L-21193
`
`90-191
`
`L-90194
`
`110-191
`
`L-90195
`
`'
`
`99191119
`
`.
`
`_
`
`'
`
`14-120
`
`021151. 310120
`
`090152
`
`NK-120
`
`0-90153
`
`9-9191119999119999 325' Cyclic 11999999599911,-
`
`11-221
`
`1111-21199
`
`9111-221
`
`14-90-97
`
`1191221
`
`1111-90199
`
`.
`
`'
`
`:Bromdcriplihe Mesylate
`
`'
`
`5-Bromo-2'-Deoxyuridine 1919111
`'-'Brucine
`.
`l'
`-.
`
`Busulfan 1111191311
`HIS-911.9199."
`-.
`
`Calycanthine
`20901919111999 --
`
`Captopril
`I-I':_:3_109I09m92febine
`Carbinoxamine
`
`--
`
`.'
`
`_
`
`_
`
`-
`
`-
`
`-
`
`2-130
`0191
`
`K-123
`' _'0-119
`
`0-117
`_ 0-113
`0-471
`
`_-
`
`.
`
`0-231
`
`13-21157
`
`90-231
`
`13-90159
`
`- 140-231
`
`E90159
`
`11-231
`- K422
`
`9-21149
`13-21151
`
`914-231
`$19122
`
`9-90149
`0-90152
`
`9-90149
`090152
`
`99049
`E-601'58
`
`990149
`0-90152
`0-90152
`
`NN-231
`NK-122
`
`9-90150
`10-90153
`
`112-130
`110-191
`
`99090
`090153
`
`NK-123
`910-119
`
`110117
`910-113
`140-471
`
`9-90150
`13-90159.
`
`13-90150
`0-90153
`0-90153
`
`9-21149
`021151
`
`9-21149
`15-21157
`
`9-21149
`0-21151
`0-21151
`
`92-130
`90191
`
`914-123
`90-119
`
`90117
`90-113
`90-471
`
`
`
`9-179
`
`11-21145
`
`99-179
`
`14-90149
`
`119-179
`
`14-90147
`
`.
`
`"
`
`'- 9-177
`
`_ 9421145
`
`99-177-
`
`14-90149'
`
`N9-1-77
`
`”11-90147:
`
`9-179
`
`141-21145
`
`99179
`
`1490149
`
`149-179
`
`11-90147
`
`'- - 'Centrwhengxiné (11199199119299)
`
`I
`
`.
`
`{3-115
`
`C-2‘U51'
`
`50-115
`
`05015-2
`
`NC-115
`
`090153
`
`Cephalexin
`
`9119
`
`921149
`
`99-119
`
`990149
`
`149119
`
`990150
`
`24
`
`AstraZeneca Exhibit 2044 p. 30
`
`11-271.
`11-215
`
`0-21151
`0-21151
`
`SV—271
`311-215
`
`090152
`090152
`
`9111-271
`1117-215
`
`0-90153
`0-90153
`
`-
`
`'-
`
`'_
`
`We 91.999919191114119 any dose'and any releaseti030.(PLEA_SE INQUIRE)
`9170
`11-21145
`99170
`990149
`119-170
`14-90147
`
`-' 91-171
`9-172
`"_'-'9_-.-'1':7'33-
`
`I
`
`'
`
`11-21145 99-171
`14-21145
`99-172
`94211451. 99173
`
`33f-
`
`'
`
`--
`
`_-
`
`I .7. 5.
`
`9-174
`11-21145
`. 29-175 __ 921145
`
`-'
`
`99-174
`99175
`
`11-90149
`14-90149
`14-90149
`
`14-90149
`1190149
`
`149-174 '. 4-90147'_
`119-172
`11-90147
`919-173.
`- 11-90147";
`
`119-174
`1119-175
`
`14-90147
`'11-'90147-
`
`”be-09111111119
`9-Carotene
`
`.
`
`I.
`
`1.
`
`.' Casodexlblcalutamlde)
`0919019in
`
`Cefamandoie
`Cefazolin
`Cefmetazole '7
`
`Cefoperazone
`CefotaXIme
`
`Cefoxilin
`
`_"0919.ulodin_ _-
`
`Cefiriaxone
`
`
`
`r-
`
`ALPHABETICAL PRODUCT LISTING—
`
`DosefPriee Schedules For Matching Placebo Pellets Appear On Pages 17-19.
`
`)
`ll‘OdllCt
`
`(Inning l-‘riue Schedule!
`Nulnlm Pa"gt
`\umbL-I'
`
`Calalug PliCi.‘ Schedule!
`Number Pant. NIIIIIIJur
`
`(Ia-nlug Price fiche-duh!
`Number Pa"gt NuIIIhLI
`
`21-Day Release
`
`60-Day Release
`
`90-Day Release
`
`Cephaloglycin
`
`8-119
`
`Ill-21.354
`
`38-119
`
`0-60155
`
`NB-119
`
`D-QUI‘SB
`
`53-21148
`
`-
`
`-
`
`Chloramphenicol
`'l‘I'lfihI-OFa'r'rIphEnicblBase
`Chlorcycsizine
`
`"
`
`_'
`
`i
`
`-
`021151
`- 0-211'51 _
`-
`I
`Isl-21143
`-
`
`C-60l52
`..
`.
`3-60349 I
`
`_
`
`-
`
`-
`
`-
`
`8-90150
`
`C—90f53
`
`3-9050
`
`'
`
`"Chloroquine
`cmw
`Chlorotrianisene
`
`géfihlorpheniramine
`__ Chlerpremazine
`:Iféhlorthalidone
`
`-
`
`-
`
`-
`
`--
`-
`-
`
`-
`C-21I’51
`cm "
`C-21I‘51
`-
`
`0-9053
`-
`0-6052
`050,52 ems
`C-SDI‘52
`0—9053
`
`'
`
`-
`
`C-‘21!51I_ '
`02151
`B-21i48'
`
`.
`
`_
`
`0-21:51
`
`~
`--
`
`-
`
`_'
`
`' 060(52
`0-6052
`1 3.60m
`
`.
`
`c-60I52
`
`:;.3:C-90!53
`c9053
`:B90505
`
`C90:53
`
`-
`
`-
`
`
`
`Chlorzoxazone
`' ff
`CImetIdIne
`Cinchonidine
`éi-finadzine
`Cieniastine
`EiléthiZQIe
`
`-
`
`Clenbuleroi
`
`.9 Ciofoctot
`
`_
`
`Clomiphene Citrate
`3 E'mipramine
`
`cIonsdine
`Hepamide
`
`_
`
`-
`
`—
`-
`-
`-
`__ -
`
`-
`
`-
`
`-.
`
`.
`
`I
`
`.
`
`-
`
`I
`
`'
`
`-
`-- .
`
`-
`;_'
`
`B-21!48
`C-21!51
`c-21I51f'
`B-21f48
`(”j-21:51.
`
`H-21I60
`
`0-2151
`
`B-21f48
`0:21:51
`
`B—21I’48
`B—2II4'85
`
`'
`
`'
`
`- I
`—
`—
`
`-
`
`-
`
`-
`
`-
`
`- 3:60:49 '- Brlaorsoa
`IC-60152
`-
`0-9053
`I @6952
`i_.};_Cz—30!j_5;3.
`B—BOMQ
`8:90150-
`04-6052
`10:90:53.5:
`
`I -
`
`I
`
`H-60I61
`
`C-eorsz-
`
`B-BOMQ
`0-6052
`
`3-60I49
`Isa-60:49
`
`-
`
`-
`
`-
`-
`
`'
`
`H-goxsz
`
`I'__-.-c.-9'01531
`
`5-9050
`39591053
`
`3-90I50
`1.3;90I'50;
`
`Clotrimazole
`
`-
`
`B-21l48
`
`-
`
`B-BOMQ
`
`-
`
`3—9050
`
`25
`
`AstraZeneca Exhibit 2044 p. 31
`
`
`
`ALPHABETICAL PRODUCT LISTING
`
`21-Day Release
`Catalog Price Selledule!
`Numl.1erl"age Nmnher
`
`60-Day Release
`
`90-Day Release
`
`Catalog Priee Hellcdule1
`Number Page Numher
`
`Catalog l’riee Scheduief
`Numher Page Number
`
`
`
`
`
`
`
`
`
`Product.
`
`
`
`13-90150
`
`
`
`
`'355490’47i}
`11-33-9155:
`1 "-14.311555 -
`8155 1121145
`
`
`
`6-301”
`1321148.
`
`13-90150
`36-301
`NG-301
`
`
`
`
`859-16151)?
`3-50149 " NG-311
`36-311
`3311 - 32-1143
`
`
`
`
`6111
`11-21145
`
`
`36-111
`11-50146
`116-111
`111-9014?
`
`
`
`
`
`
`
`364.171 '
`' 121-90147 -'
`-A_-60146
`'
`' 11-21145-
`
`
`
`13-90150
`13-21148
`36121
`350149
`
`
`
`
`13-50149
`13-90150
`13-21148
`36-181
`
`
`
`
`
`
`
`1121145
`11-90147
`A-60146
`310124
`
`
`
`
`
`
`SCI-112
`C-501’52
`NC-112
`C-901'53.
`0-21351
`
`
`
`
`
`
`
`
`13-21148
`36-195
`13-80149
`13-90150
`
`
`D~21154
`3K-125
`D-601’55
`0-30156
`
`
`
`
`
`
`6-108
`11-21145
`36-108
`A-60146
`11-90147
`
`
`
`
`
`A-21145
`32- 150
`11-60146
`
`
`131-90147
`
`
`
`
`
`
`
`88-128
`B-601’49
`B-211'48
`8-90150
`
`
`
`
`
`
`
`13-21154
`36-382
`13-80155
`0-90153
`
`
`101-21145
`SCI-4B1
`101-50146
`15-9014?
`
`
`
`
`521-157
`80114
`E60158
`NC-114
`59.0159
`
`
`
`
`
`36-201
`650152
`6-201
`6-21151
`690153
`
`
`
`
`
`
`
`6'-80152
`0-90153
`36-211
`_- 0-211
`6-2-1151
`
`
`
`
`
`
`13-21154
`36-221
`0-50155
`0-90156
`
`
`
`
`
`
`36-231
`650152
`0-90153
`
`
`D-211‘54
`82- 160
`0—60155
`0430156
`
`
`
`
`
`
`
`
`
`
`15-21157
`E30158
`E80158
`7 .6y11sme
` SK- 1-26
`
`
`
`
`
`
`
`6-21151
`311-241
`0-60152
`690153
`
`
`
`9-251
`0-21154
`313-251
`D-60155
`13-90155
`
`
`
`
` Daunorubucine
`H-21160
`82- 110
`H60161
`H-90152
`
`
`
`Cloxacillin
`
`13-21148
`
`38-127
`
`
`
`13-50149
`
`
`
`
`
`
`Conexolone
`
`
`
`Corticosterone
`
`Corticosterone2191fiéetat'e-
`
`'
`
`'
`
`Cortisone
`
`_'.=cofiésqh_é Acetate;
`
`_
`
`(-)Coiinine
`
`'Coumarin'11;_2 'Benzopymney
`
`Cromo1yn
`
`"
`
`.CrotalineI-J
`
`Cyciizine
`
`-Cyclopho'sp'hamide(6110113111
`
`D-Cycioserine
`
`-
`'f-"Cymarin
`”Cyproheptadine
`I Cyprete10063gcetate
`D-Cy3teine
`I
`L6ys1eme
`
`D-Cystine
`
`'
`
`_ 8.50146 '
`3-60149
`
`K-124
`
`l'
`
`LCystane
`
`'
`
`6-231
`
`6-21151
`
`Cy’tarabine {Cytosine Arabinoside}
`
`"
`
`Cytosine
`
`I [Danazol
`
`26
`
`AstraZeneca Exhibit 2044 p. 32
`
`
`
`1|
`
`
`
`'r-
`
`ALPHABETICAL PRODUCT LISTING—
`
`DosefPrice Schedules For Matching Placebo Pellets Appear 0!! Pages 17-19.
`
`=336
`
`1.150
`
`PFOduct
`
`21-Day Release
`Calming Price Schedule!
`Number Page Number
`
`60-Day Release
`taming Price Schedule)
`Number Page Number
`
`90-Day Release
`lffltnlng Price Schedule!
`Number Page Number
`
`3-Deazauracil
`
`E's-21148
`
`SN-251
`
`B-GOMQ
`
`NN—251
`
`8-90150
`
`Mi 1 1ewmawsua "a:
`1150
`I Decamethonium Bromide
`
`irmxsvitjl=
`B-21f48
`30-112
`
`
`
`i
`
`ND-112
`
`8-90150
`
`“fiwmmwmm-w.-*mi
`I 7-Dehydrocholesterol
`
`.«meaéwmezr
`c-2151
`SV-281
`
`“fidfibho'lfldd
`
`
`:
`
`”
`
`.i02115130114
`
`090153
`
`vw-
`1147
`
`”47"
`
`if50
`we
`'34?
`1153
`i1'50
`1156
`”47
`:14?
`|:‘50
`1156
`”'47
`'59
`:53
`1:53
`
`#56
`1153
`1156
`
`:59
`
`I153
`
`I156
`
`I:‘82
`
`-_
`
`_
`
`-
`
`Dehydroepiandrosterone [DHEA]
`;®wmmwwmmmmaf-i'
`I Dehydroepiandrosterone Sulfate I
`
`jilgfiehydropregnenolo'ne'_
`H16-Dehydropregnenolone Acetate
`if}?-.1.'f:3§Dehydroprogesterone
`Demeclocycline
`fii-Deoxychonc Acid
`”DeoxycoflicosleronemOC)
`E_:£ijDt'eoxycorticoslerone Adelate (00cm
`I Desipramine
`332;:"D'esbximetasone
`
`pexamemasone
`ffbexamemasone 21-.Acetate
`
`
`-
`
`-
`
`;
`
`" '
`
`.
`
`'
`
`-
`
`8-21148
`SA-111
`3-60149
` 3$@53¢57%®5 :7’
`ISL-2.1154- SD-11B
`III-60155
`H
`I.
`B21148 SP271
`360.149
`B-QOIS-{J
`U
`I
`B-21!48
`SP-281
`B-BOMQ
`3-21148';
`:SP'-2'61 860149 390150
` B~90i50
`8-21148-
`80-121
`3-60.49
`' 0211.51- 30-110 - ems:
`-
`53-.1090153
`B-21i48
`SIM-111
`B-GOMQ
`B-QDISOH
`331421345“ __SM-_1-21
`#60146: [-
`3'_,q;'9(}347.:-
`3-21148
`30491
`8-601'49-
`B-gfll‘5d
`.'_D-'2'1!54-II_SD.-10% D6055-
`75193055
`0-21154'
`36-131
`0-50155
`__
`13-9-0156
`b22154:
`$64201
`$60155 jg
`f"- 090156
`
`I
`
`I.
`
`-'
`
`_
`
`Dexamethasone 21-Phosphate
`Di’ayeridine
`NE-OZ-Dibutyryladenosine-
`1:11....3’_:.5'-.Cyclic Monophosphate
`EfDliclofenae
`-
`
`'
`
`Dicloxacillin
`
`Dien'éstroi
`
`_
`
`_
`
`_
`
`D-21I'54
`80-108
`0-2154.” 53-129;
`-
`_
`L 21f63
`SN 271
`B-21l48i-
`SX--1_3'5
`
`0-90.56
`0-50355
`-_'p'§901561
`- 060155-15
`_
`_
`L 9955.
`L 60!“
`13-60149; 3112;135; 39050
`
`3-21143
`
`83-156
`
`B-BOMQ
`
`NIB-156
`
`13-90150
`
`0.21151,
`
`'35- 1817 06.652
`
`vast-181.5_=:éj-9b?53¥1
`
`'
`
`_
`
`'
`
`'
`
`..
`
`DienestrolDiacetate
`
`0-21151
`
`SE-191
`
`060152
`
`NE-191
`
`AstraZeneca Exhibit 2044 p. 33
`
`
`
`ALPHABETICAL PRODUCT LISTING I
`
`I
`
`21-Day Release
`(.‘ulalug l-‘riee Schedule!
`Number Page
`.Vumher
`
`60-Day Release
`($012110: Price Schedule!
`Number Page Number
`
`90—Day Release
`(Ialalng I'riee Schedule!
`Number Page Number
`
`DIeIhyIstiIbestroIInesI
`
`5-151
`
`5-2043
`
`35-151
`
`5430149
`
`rue-151
`
`5-90150
`
`_
`
`I
`
`I
`
`I
`
`3019555914900195 1390150
`
`5-2-1149 30-271
`13-50149
`00-221 5-901-502-
`0-2731“.
`- 542-11521,'..$.K-j'-1'2?'.. 550155 4519.127 £9059
`K12?
`Special Dosing For Immune-Deficient Mice. See pages 78-80
`511--Dihydr0testosterone
`{See Controlled Subs!311055 Page 3)
`".A'-.16:1= "IA-2.1145 --SA_-.16_1_ : A-GOMG'
`-_NA-.161
`5-9054? '5
`2'L3.i,50-0Ihydrotestosterone
`-.
`-
`Immmmwameagea}
`r
`-
`--
`-_
`-
`-
`..
`.
`"
`'.
`500Ihydrotestosterone
`0105
`0-2054
`30-103
`050155
`190-100
`0-9055
`
`'
`
`I'.._?'.';350IIodo-0LThyronme '
`3.5Diiodo-L—T-hyronine
`
`I
`
`-.
`I
`
`I
`
`I
`
`3
`_
`_-';-:z._i_-'15Imenhydnnate ._
`9, 10--Uimethyl-,12-5enzanthracene
`
`'
`
`I
`
`_
`
`Dlpyrldamole
`Di0yrone I
`?'-';._.E}:i300_31r5111ldg.
`01's'uIrIrém
`
`I
`
`'
`
`.
`
`.
`
`-
`
`I
`
`3
`
`.
`
`'
`
`.
`
`:-
`
`_
`
`-
`
`52-31
`7-241
`
`5-211149'
`5-21149
`
`_’_3'T- 231
`3T-241
`
`3-601‘49
`5-50149
`
`NT- 231
`NT-241
`
`f 0-205
`I 0-117
`
`0-101
`0-102
`f._.0'-500
`0-109
`
`0-21151'
`9-2045
`
`I 5-2045
`0-2051
`5-2045
`0-2051
`
`30-205
`30-117
`
`30-101
`30-102
`30-500
`30-109
`
`0-60152-
`4-5005
`
`.NC-205
`110-117
`
`5-90149
`0-5052
`5-00149
`0-5052
`
`140-101
`110-102
`N0-500
`N0-109
`
`590150
`5-90150
`
`0-9053
`9-9014?
`
`59050
`0-90153
`5-90I50
`0-90-53
`
`-
`
`_
`
`'-
`
`_
`
`
`
`-'0-501
`0-502
`
`I
`
`-. 0-503
`0-151
`_"0-325
`5165
`
`'
`
`'_ 5-2049
`0-21151
`
`30-501
`30-502
`
`550149
`0-50152
`
`0-2051
`0-21151
`-__5-21I.43‘-
`III-21145
`
`:
`
`050152
`30503
`0-50152
`30-151
`30-325 550149
`35-155
`III-90146
`
`N0-501
`NC-502
`
`190-503
`NC-151
`140-325
`195-105
`
`51-90150
`030153
`
`0-9.0153
`0-90153
`590150
`A-QOM?
`
`0-504". 30-21-1511"
`